Copeptin (human)
CHF 337.10 – CHF 618.50
Pack size available | 0.5mg, 1mg |
---|
Please select pack size:
Product Description
Copeptin (CT-proAVP) is initially produced in equimolar amounts to (Arg⁸)-Vasopressin (AVP). Due to the high stability of copeptin in plasma and serum its measurement is not affected by the problems, which are associated with the direct measurement of AVP, and thus, is suitable to indirectly determine the release of AVP. Copeptin has emerged as a prognostic marker in a variety of diseases, such as sepsis, community-acquired pneumonia, chronic obstructive pulmonary failure, heart failure and myocardial infarction.